Is there an optimal method for measuring baseline metabolic tumor volume in diffuse large B cell lymphoma?-Reference-Cited by-同舟云学术

Is there an optimal method for measuring baseline metabolic tumor volume in diffuse large B cell lymphoma?

Published:2018-04-12 Issue:8 Volume:45 Page:1463-1464
ISSN:1619-7070
Container-title:European Journal of Nuclear Medicine and Molecular Imaging
language:en
Short-container-title:Eur J Nucl Med Mol Imaging

Author:

Cottereau Anne-Ségolène^ORCID,Buvat Irene,Kanoun Salim,Versari Annibale,Casasnovas Olivier,Chauvie Stephane,Clerc Jérôme,Gallamini Andrea,Meignan Michel

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,General Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

Link

http://link.springer.com/article/10.1007/s00259-018-4005-4/fulltext.html

Reference13 articles.

1. Ilyas H, Mikhaeel NG, Dunn JT, Rahman F, Moller H, Smith D, et al. Defining the optimal method for measuring baseline metabolic tumour volume in diffuse large B cell lymphoma. Eur J Nucl Med Mol Imaging. 2018. https://doi.org/10.1007/s00259-018-3953-z .

2. Kanoun S, Tal I, Berriolo-Riedinger A, Rossi C, Riedinger JM, Vrigneaud JM, et al. Influence of software tool and methodological aspects of total metabolic tumor volume calculation on baseline [18F]FDG PET to predict survival in Hodgkin lymphoma. PLoS One. 2015;10:e0140830. https://doi.org/10.1371/journal.pone.0140830 .

3. Cottereau AS, Hapdey S, Chartier L, Modzelewski R, Casasnovas O, Itti E, et al. Baseline total metabolic tumor volume measured with fixed or different adaptive thresholding methods equally predicts outcome in peripheral T cell lymphoma. J Nucl Med. 2017;58:276–81. https://doi.org/10.2967/jnumed.116.180406 .

4. Toledano MN, Desbordes P, Banjar A, Gardin I, Vera P, Ruminy P, et al. Combination of baseline FDG PET/CT total metabolic tumour volume and gene expression profile have a robust predictive value in patients with diffuse large B-cell lymphoma. Eur J Nucl Med Mol Imaging. 2018. https://doi.org/10.1007/s00259-017-3907-x .

5. Sasanelli M, Meignan M, Haioun C, Berriolo-Riedinger A, Casasnovas RO, Biggi A, et al. Pretherapy metabolic tumour volume is an independent predictor of outcome in patients with diffuse large B-cell lymphoma. Eur J Nucl Med Mol Imaging. 2014;41:2017–22. https://doi.org/10.1007/s00259-014-2822-7 .

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The prognostic utility of 18F-FDG PET parameters in lymphoma patients under CAR-T-cell therapy: a systematic review and meta-analysis;Frontiers in Immunology;2024-09-02

2. International Benchmark for Total Metabolic Tumor Volume Measurement in Baseline¹⁸F-FDG PET/CT of Lymphoma Patients: A Milestone Toward Clinical Implementation;Journal of Nuclear Medicine;2024-08-01

3. Evaluation of a convolution neural network for baseline total tumor metabolic volume on [18F]FDG PET in diffuse large B cell lymphoma;European Radiology;2023-01-04

4. Multi-scale feature similarity-based weakly supervised lymphoma segmentation in PET/CT images;Computers in Biology and Medicine;2022-12

5. Technologist-Based Implementation of Total Metabolic Tumor Volume into Clinical Practice;Journal of Nuclear Medicine Technology;2022-11-09